SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
accepted and acknowledged
on 15 Nov 2023
Last Applicant/ Owned by
4242 Campus Point Court, Suite 200
San Diego
CA
92121
Serial Number
87101607 filed on 12th Jul 2016
Registration Number
5419060 registered on 06th Mar 2018
Correspondent Address
Beth M. Goldman
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
CINVANTI
Anti-emetic pharmaceutical preparations; pharmaceutical preparations for human and animal use for the treatment of pain, for gastrointestinal conditions, cancer, post-operative, chemotherapy-induced nausea and vomiting, autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases, cardiovascular diseases, orthopedic conditions, and for immunotherapy
Classification Information
Class [005]
Pharmaceutical Products
Anti-emetic pharmaceutical preparations; pharmaceutical preparations for human and animal use for the treatment of pain, for gastrointestinal conditions, cancer, post-operative, chemotherapy-induced nausea and vomiting, autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases, cardiovascular diseases, orthopedic conditions, and for immunotherapy
First Use Date in General
03rd Jan 2018
First Use Date in Commerce
03rd Jan 2018
Mark Details
Serial Number
No 87101607
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 21539-6000
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 15th Nov 2023 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| 15th Nov 2023 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| 14th Nov 2023 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 16th Aug 2023 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 16th May 2023 | TEAS SECTION 8 & 15 RECEIVED |
| 06th Mar 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 12th Mar 2018 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 12th Mar 2018 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 06th Mar 2018 | REGISTERED-PRINCIPAL REGISTER |
| 30th Jan 2018 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |